The exciting news about Blueprint Medicines Corporation (NASDAQ: BPMC) will be shared on Wednesday 30th October 2024. Investors and analysts are eagerly waiting to hear about the company's financial performance for the third quarter of 2024. This significant announcement will happen before market open.
Financial analysts on Wall Street are anticipating that the firm will announce an estimated $0.96 loss per share for the quarter. Furthermore, the firm is projected to disclose a total revenue of $127.03 million for this period.
Analysts forecasting the company's performance for this year have been made public. The estimated total revenue is about $497.78 million. They also predict that throughout the course of the fiscal year, the business will make about loss of $1.23 per share.
In the corresponding quarter of the previous year, the company's earnings report revealed a per-share loss of $2.2. This significant amount was attributed to the company's remarkable total revenue of $56.57 million generated during that specific period.
In addition, The firm will review the third quarter financial results on 30th October 2024 at 08:00 AM eastern time, in a conference call with public.
Throughout Monday's trading, Blueprint Medicines Corporation (BPMC) shares fluctuated between $81.67 and $84.64, with a trading volume of 633.90 thousand shares. The stock ended the regular trading session at $82.77, indicating an upturn of 0.36 percent.
